Børge G. Nordestgaard
Surgery · 2006–2024
A researcher in the Science corpus: 41 papers; trusts 15 researchers and is trusted by 17 researchers here, as inferred from the citation graph.
Subfields
- Surgery — 260 citations into it; #62 of 1,106 by trust here, #30 by citations
- Endocrinology, Diabetes and Metabolism — 213 citations into it; #40 of 623 by trust here, #75 by citations
- Cardiology and Cardiovascular Medicine — 145 citations into it; #804 of 906 by trust here, #86 by citations
- Genetics — 135 citations into it
- Epidemiology — 73 citations into it; #666 of 2,148 by trust here, #129 by citations
- Economics and Econometrics — 49 citations into it
- Pulmonary and Respiratory Medicine — 44 citations into it
- Physiology — 27 citations into it
Whom Børge G. Nordestgaard trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- B. J. Gersh
- M. Benn
- George Davey Smith
- G. Moneta
- A. Varbo
- J. Buring
- P. P. Toth
- A. Tybjærg-Hansen
- N. Rifai
- Shah Ebrahim
Who trusts Børge G. Nordestgaard overall
Papers from Børge G. Nordestgaard's perspective
Ordered by how strongly the researchers Børge G. Nordestgaard trusts endorse each paper. Same corpus, a different order for every researcher.
- Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. (Journal of the American Medical Association (JAMA))
- Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology (Statistics in Medicine)
- Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.
- Lipoprotein(a) as a cardiovascular risk factor: current status (European Heart Journal)
- Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. (Journal of the American College of Cardiology)
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management (European Heart Journal)
- Reprint: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. (Journal of the American Pharmacists Association)
- Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study (Circulation)
- Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans (Nature Genetics)
- Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. (Journal of the American Medical Association (JAMA))
Their papers
- The UK10K project identifies rare variants in health and disease (2015) — 1,063 citations
- A common coding variant in CASP8 is associated with breast cancer risk (2007) — 597 citations
- Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women (2021) — 858 citations
- Association of Cardiometabolic Multimorbidity With Mortality. (2015) — 954 citations
- Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (2018) — 797 citations
- Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants (2024) — 676 citations
- Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults (2024) — 1,570 citations
- Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement (2022) — 1,097 citations
- SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. (2021) — 1,383 citations
- Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society (2021) — 742 citations
- Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel (2020) — 1,302 citations
- World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions (2019) — 908 citations
- Systematic Evaluation of Pleiotropy Identifies 6 Further Loci Associated With Coronary Artery Disease (2017) — 244 citations
- Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes (2017) — 401 citations
- Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Med (2016) — 805 citations
- Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology. (2016) — 934 citations
- Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management (2015) — 1,260 citations
- Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment (2015) — 768 citations
- Improved imputation of low-frequency and rare variants using the UK10K haplotype reference panel (2015) — 384 citations
- Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease (2014) — 1,133 citations